Abstract
An 18-year-old man with tuberous sclerosis was studied with I-123 Iomazenil SPECT and the findings were compared with those of MRI. In all cortical tubers detected with MRI, I-123 iomazenil binding 180-191 minutes after intravenous administration was decreased significantly. This result indicates that the binding potential of I-123 Iomazenil is decreased in cortical tubers.
Original language | English (US) |
---|---|
Pages (from-to) | 130-131 |
Number of pages | 2 |
Journal | Clinical Nuclear Medicine |
Volume | 22 |
Issue number | 2 |
DOIs | |
State | Published - 1997 |
ASJC Scopus subject areas
- Radiology Nuclear Medicine and imaging